U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07287280) titled 'Comparing CCI and POSSUM for Predicting Oncogynecologic Surgery Complications' on June 23.
Brief Summary: With the global rates of gynecologic cancers on the rise, optimizing perioperative care is imperative. Accurate risk prediction is essential for enhancing patient care, directing preoperative interventions, and facilitating informed decision-making in oncology. This research compares two widely-used risk assessment tools: the Charlson Comorbidity Index (CCI) and the Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity (POSSUM), in predicting perioperative outcomes. The CCI predominantly addre...